ProShare Advisors’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10,028
Closed -$123K 2015
2025
Q2
$123K Sell
10,028
-671
-6% -$8.44K ﹤0.01% 1833
2025
Q1
$153K Sell
10,699
-2,994
-22% -$46.7K ﹤0.01% 1755
2024
Q4
$218K Buy
13,693
+4,210
+44% +$83.3K ﹤0.01% 1845
2024
Q3
$228K Buy
+9,483
New +$217K ﹤0.01% 1655
2022
Q2
Sell
-10,703
Closed -$357K 1819
2022
Q1
$357K Sell
10,703
-1,321
-11% -$42.5K ﹤0.01% 1508
2021
Q4
$416K Buy
12,024
+4,614
+62% +$149K ﹤0.01% 1581
2021
Q3
$231K Sell
7,410
-6,382
-46% -$217K ﹤0.01% 1713
2021
Q2
$502K Sell
13,792
-2,658
-16% -$110K ﹤0.01% 1540
2021
Q1
$720K Buy
16,450
+2,152
+15% +$101K ﹤0.01% 1196
2020
Q4
$656K Buy
14,298
+5,234
+58% +$218K ﹤0.01% 1096
2020
Q3
$301K Sell
9,064
-1,339
-13% -$42.8K ﹤0.01% 1173
2020
Q2
$306K Buy
+10,403
New +$301K ﹤0.01% 1216
2020
Q1
Sell
-11,620
Closed -$392K 1202
2019
Q4
$392K Buy
11,620
+1,521
+15% +$55.1K ﹤0.01% 1195
2019
Q3
$378K Buy
10,099
+200
+2% +$7.63K ﹤0.01% 1099
2019
Q2
$432K Sell
9,899
-1,030
-9% -$44.1K ﹤0.01% 1069
2019
Q1
$466K Buy
10,929
+1,450
+15% +$64.9K ﹤0.01% 1038
2018
Q4
$425K Sell
9,479
-1,830
-16% -$95.9K ﹤0.01% 1006
2018
Q3
$775K Buy
11,309
+10
+0.1% +$644 0.01% 932
2018
Q2
$647K Buy
11,299
+156
+1% +$8.24K ﹤0.01% 1004
2018
Q1
$513K Sell
11,143
-1,103
-9% -$52.4K ﹤0.01% 1084
2017
Q4
$566K Buy
12,246
+4,932
+67% +$227K ﹤0.01% 1068
2017
Q3
$329K Sell
7,314
-1,023
-12% -$43.7K ﹤0.01% 1105
2017
Q2
$327K Sell
8,337
-1,907
-19% -$72.1K ﹤0.01% 1124
2017
Q1
$390K Sell
10,244
-2,635
-20% -$103K ﹤0.01% 1110
2016
Q4
$476K Buy
12,879
+3,735
+41% +$133K 0.01% 1101
2016
Q3
$317K Sell
9,144
-2,213
-19% -$77.5K ﹤0.01% 1130
2016
Q2
$369K Buy
11,357
+70
+0.6% +$2.14K ﹤0.01% 1099
2016
Q1
$324K Sell
11,287
-1,529
-12% -$40.7K ﹤0.01% 1176
2015
Q4
$428K Buy
12,816
+2,917
+29% +$90.7K 0.01% 1113
2015
Q3
$282K Sell
9,899
-4,366
-31% -$152K ﹤0.01% 1171
2015
Q2
$578K Buy
14,265
+5,596
+65% +$251K 0.01% 1036
2015
Q1
$427K Sell
8,669
-1,022
-11% -$47.3K 0.01% 1263
2014
Q4
$441K Buy
+9,691
New +$381K 0.01% 1264

Other funds holding AVNS